Effects of COVID19 Pandemic on Pediatric Kidney Transplant in the United States
Olga Charnaya(Johns Hopkins University), Jacqueline Garonzik‐Wang(University of Wisconsin–Madison), Teresa Po‐Yu Chiang(Johns Hopkins University), Allan B. Massie(Johns Hopkins University), Elizabeth King(Johns Hopkins University), Dorry L. Segev(New York University), Jennifer D. Motter(Johns Hopkins University), William A. Werbel(Johns Hopkins University), Brian J. Boyarsky(Johns Hopkins University), Robin K. Avery(Johns Hopkins University), Richard Wang(New York Medical College), Christine M. Durand(University of Maryland, Baltimore)
Cited by 8
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k